FdaApplication
ANDA 205942
Identifiers
- fda_app_no: ANDA205942
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMS |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAXAGLIPTIN;METFORMIN HYDROCHLORIDE | SAXAGLIPTIN; METFORMIN HYDROCHLORIDE | 5MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
| SAXAGLIPTIN;METFORMIN HYDROCHLORIDE | SAXAGLIPTIN; METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET, EXTENDED RELEASE;ORAL |
| SAXAGLIPTIN;METFORMIN HYDROCHLORIDE | SAXAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
3 products